These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations. Conceição I; Damy T; Romero M; Galán L; Attarian S; Luigetti M; Sadeh M; Sarafov S; Tournev I; Ueda M Amyloid; 2019 Mar; 26(1):3-9. PubMed ID: 30793974 [TBL] [Abstract][Full Text] [Related]
9. How to Identify Transthyretin Cardiac Amyloidosis at an Early Stage. Izumiya Y; Hayashi H; Ishikawa H; Shibata A; Yoshiyama M Intern Med; 2021 Jan; 60(1):1-7. PubMed ID: 32713926 [TBL] [Abstract][Full Text] [Related]
10. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings. Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367 [TBL] [Abstract][Full Text] [Related]
11. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis. Maurer MS; Bokhari S; Damy T; Dorbala S; Drachman BM; Fontana M; Grogan M; Kristen AV; Lousada I; Nativi-Nicolau J; Cristina Quarta C; Rapezzi C; Ruberg FL; Witteles R; Merlini G Circ Heart Fail; 2019 Sep; 12(9):e006075. PubMed ID: 31480867 [TBL] [Abstract][Full Text] [Related]
12. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy. Paton DM Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875 [TBL] [Abstract][Full Text] [Related]
13. [Transthyretin-related hereditary amyloidosis]. Vionnet J; Pascual M; Kuntzer T; Yerly P; Moradpour D Rev Med Suisse; 2016 Aug; 12(528):1434-1440. PubMed ID: 28675284 [TBL] [Abstract][Full Text] [Related]
14. Assessment of patients with hereditary transthyretin amyloidosis - understanding the impact of management and disease progression. Conceição I; Coelho T; Rapezzi C; Parman Y; Obici L; Galán L; Rousseau A Amyloid; 2019 Sep; 26(3):103-111. PubMed ID: 31339362 [TBL] [Abstract][Full Text] [Related]
15. Hereditary ATTR amyloidosis: a single-institution experience with 266 patients. Swiecicki PL; Zhen DB; Mauermann ML; Kyle RA; Zeldenrust SR; Grogan M; Dispenzieri A; Gertz MA Amyloid; 2015; 22(2):123-31. PubMed ID: 26017327 [TBL] [Abstract][Full Text] [Related]
16. Frequencies and geographic distributions of genetic mutations in transthyretin- and non-transthyretin-related familial amyloidosis. Zhen DB; Swiecicki PL; Zeldenrust SR; Dispenzieri A; Mauermann ML; Gertz MA Clin Genet; 2015 Oct; 88(4):396-400. PubMed ID: 25211232 [TBL] [Abstract][Full Text] [Related]
17. Amyloid Cardiomyopathy in the Rare Transthyretin Tyr78Phe Mutation. Tini G; Vianello PF; Gemelli C; Grandis M; Canepa M J Cardiovasc Transl Res; 2019 Dec; 12(6):514-516. PubMed ID: 30604309 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR). Phull P; Sanchorawala V; Connors LH; Doros G; Ruberg FL; Berk JL; Sarosiek S Amyloid; 2018 Mar; 25(1):62-67. PubMed ID: 29424556 [TBL] [Abstract][Full Text] [Related]
19. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan. Yamashita T; Ueda M; Misumi Y; Masuda T; Nomura T; Tasaki M; Takamatsu K; Sasada K; Obayashi K; Matsui H; Ando Y J Neurol; 2018 Jan; 265(1):134-140. PubMed ID: 29177547 [TBL] [Abstract][Full Text] [Related]
20. Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy? Aus dem Siepen F; Hein S; Prestel S; Baumgärtner C; Schönland S; Hegenbart U; Röcken C; Katus HA; Kristen AV Clin Res Cardiol; 2019 Dec; 108(12):1324-1330. PubMed ID: 30953182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]